(19)
(11) EP 1 196 436 A2

(12)

(88) Date of publication A3:
19.07.2001

(43) Date of publication:
17.04.2002 Bulletin 2002/16

(21) Application number: 00943413.5

(22) Date of filing: 07.07.2000
(51) International Patent Classification (IPC)7: C07K 14/18, C07K 5/062, C07K 5/083, C07K 5/113, C07F 5/02, A61K 31/69, A61K 38/04, A61K 38/16, A61P 31/14
(86) International application number:
PCT/US0018/655
(87) International publication number:
WO 0102/424 (11.01.2001 Gazette 2001/02)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
LT LV RO SI

(30) Priority: 07.07.1999 US 142561 P

(71) Applicant: Bristol-Myers Squibb Pharma Company
Princeton,New Jersey 08443-4000 (US)

(72) Inventors:
  • KETTNER, Charles, A.
    Wilmington, DE 19803 (US)
  • JAGANNATHAN, Sharada
    Wilmington, DE 19809 (US)
  • FORSYTH, Timothy, Patrick
    Niskayuna, NY 12309 (US)

(74) Representative: Howard, Paul Nicholas et al
Carpmaels & Ransford43 Bloomsbury Square
London WC1A 2RA
London WC1A 2RA (GB)

   


(54) PEPTIDE BORONIC ACID INHIBITORS OF HEPATITIS C VIRUS PROTEASE